<VariationArchive VariationID="3363" VariationName="NM_144997.7(FLCN):c.1285dup (p.His429fs)" VariationType="Duplication" Accession="VCV000003363" Version="64" RecordType="classified" NumberOfSubmissions="28" NumberOfSubmitters="27" DateLastUpdated="2024-07-29" DateCreated="2013-04-04" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="18402" VariationID="3363">
      <GeneList>
        <Gene Symbol="FLCN" FullName="folliculin" GeneID="201163" HGNC_ID="HGNC:27310" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="17212212" stop="17237330" display_start="17212212" display_stop="17237330" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="17115525" stop="17140501" display_start="17115525" display_stop="17140501" Strand="-" />
          </Location>
          <OMIM>607273</OMIM>
          <Haploinsufficiency last_evaluated="2023-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FLCN">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FLCN">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_144997.7(FLCN):c.1285dup (p.His429fs)</Name>
      <CanonicalSPDI>NC_000017.11:17216394:GGGGGGGG:GGGGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>17p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="17216394" stop="17216395" display_start="17216394" display_stop="17216395" variantLength="1" positionVCF="17216394" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="17119708" stop="17119709" display_start="17119708" display_stop="17119709" variantLength="1" positionVCF="17119708" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
      </Location>
      <OtherNameList>
        <Name>p.His429Profs*27</Name>
      </OtherNameList>
      <ProteinChange>H447fs</ProteinChange>
      <ProteinChange>H429fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_325t1" sequenceAccession="LRG_325t1" change="c.1285dup">
            <Expression>LRG_325t1:c.1285dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_325p1" sequenceAccession="LRG_325p1" change="p.His429delinsProArgfs">
            <Expression>LRG_325p1:p.His429delinsProArgfs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_325" sequenceAccession="LRG_325" change="g.25794dup">
            <Expression>LRG_325:g.25794dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.17119716dup" Assembly="GRCh37">
            <Expression>NC_000017.10:g.17119716dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.17216402dup" Assembly="GRCh38">
            <Expression>NC_000017.11:g.17216402dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008001.2" sequenceAccession="NG_008001" sequenceVersion="2" change="g.25794dup">
            <Expression>NG_008001.2:g.25794dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353229.2" sequenceAccession="NM_001353229" sequenceVersion="2" change="c.1339dup">
            <Expression>NM_001353229.2:c.1339dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340158.1" sequenceAccession="NP_001340158" sequenceVersion="1" change="p.His447fs">
            <Expression>NP_001340158.1:p.His447fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353230.2" sequenceAccession="NM_001353230" sequenceVersion="2" change="c.1285dup">
            <Expression>NM_001353230.2:c.1285dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340159.1" sequenceAccession="NP_001340159" sequenceVersion="1" change="p.His429fs">
            <Expression>NP_001340159.1:p.His429fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001353231.2" sequenceAccession="NM_001353231" sequenceVersion="2" change="c.1285dup">
            <Expression>NM_001353231.2:c.1285dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001340160.1" sequenceAccession="NP_001340160" sequenceVersion="1" change="p.His429fs">
            <Expression>NP_001340160.1:p.His429fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_144997.7" sequenceAccession="NM_144997" sequenceVersion="7" change="c.1285dup" MANESelect="true">
            <Expression>NM_144997.7:c.1285dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_659434.2" sequenceAccession="NP_659434" sequenceVersion="2" change="p.His429fs">
            <Expression>NP_659434.2:p.His429fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_144997.5" sequenceAccession="NM_144997" sequenceVersion="5" change="c.1285_1286insC">
            <Expression>NM_144997.5:c.1285_1286insC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_144997.5" sequenceAccession="NM_144997" sequenceVersion="5" change="c.1285dup">
            <Expression>NM_144997.5:c.1285dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_144997.7" sequenceAccession="NM_144997" sequenceVersion="7" change="c.1285dupC" MANESelect="true">
            <Expression>NM_144997.7:c.1285dupC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_144997.6" sequenceAccession="NM_144997" sequenceVersion="6" change="c.1285dup">
            <Expression>NM_144997.6:c.1285dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA090951" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="607273.0001" DB="OMIM" />
        <XRef Type="rs" ID="80338682" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_144997.7(FLCN):c.1285dup (p.His429fs) AND Birt-Hogg-Dube syndrome" Accession="RCV000003529" Version="34">
        <ClassifiedConditionList TraitSetID="860">
          <ClassifiedCondition DB="MedGen" ID="C0346010">Birt-Hogg-Dube syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-11" SubmissionCount="13">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_144997.7(FLCN):c.1285dup (p.His429fs) AND Familial spontaneous pneumothorax" Accession="RCV000003530" Version="18">
        <ClassifiedConditionList TraitSetID="861">
          <ClassifiedCondition DB="MedGen" ID="C1868193">Familial spontaneous pneumothorax</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-05" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_144997.7(FLCN):c.1285dup (p.His429fs) AND not provided" Accession="RCV000082626" Version="46">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-02-06" SubmissionCount="9">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_144997.7(FLCN):c.1285dup (p.His429fs) AND Hereditary cancer-predisposing syndrome" Accession="RCV000130568" Version="16">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-03-02" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_144997.7(FLCN):c.1285dup (p.His429fs) AND multiple conditions" Accession="RCV002490302" Version="8">
        <ClassifiedConditionList TraitSetID="53643">
          <ClassifiedCondition DB="MedGen" ID="C0346010">Birt-Hogg-Dube syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0346629">Colorectal cancer</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1868193">Familial spontaneous pneumothorax</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="CN074294">Nonpapillary renal cell carcinoma</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2931246">Potocki-Lupski syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-09-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_144997.7(FLCN):c.1285dup (p.His429fs) AND FLCN-related disorder" Accession="RCV003934796" Version="2">
        <ClassifiedConditionList TraitSetID="89489">
          <ClassifiedCondition>FLCN-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-06" NumberOfSubmissions="28" NumberOfSubmitters="27" DateCreated="2013-04-04" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12204536</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12471204</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15852235</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17496196</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18234728</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18505456</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19562744</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20522427</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21538689</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23784378</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26028485</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26402642</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27220747</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27734835</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27905298</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29357828</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29548312</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30360018</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31471370</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31958439</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33137092</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33294559</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34008892</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">35221599</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">35578266</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">35946080</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301695</ID>
          <ID Source="BookShelf">NBK1522</ID>
        </Citation>
        <DescriptionHistory Dated="2023-07-15">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2023-07-03">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="89489" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="69990" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">FLCN-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">FLCN-related condition</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="53643" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="8007" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CHROMOSOME 17p11.2 DUPLICATION SYNDROME</ElementValue>
                <XRef Type="MIM" ID="610883" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Potocki-Lupski syndrome</ElementValue>
                <XRef ID="320523" DB="GeneTests" />
                <XRef ID="Potocki-Lupski+syndrome/5903" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012574" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Duplication 17p11.2 syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Potocki-Lupski syndrome (dup(17)(p11.2p11.2))</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Chromosome 17, trisomy 17p11 2</ElementValue>
                <XRef ID="Chromosome+17%2C+Trisomy+17p11+2/1476" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Trisomy 17p11 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Duplication 17p11 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PTLS</ElementValue>
                <XRef Type="MIM" ID="610883" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10145" />
                <XRef ID="10145" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Potocki-Lupski syndrome (PTLS) is characterized by cognitive, behavioral, and medical manifestations. Cognitively, most individuals present with developmental delay, later meeting criteria for moderate intellectual disability. Behaviorally, issues with attention, hyperactivity, withdrawal, and anxiety may be seen. Some individuals meet criteria for autism spectrum disorder. Medically, hypotonia, oropharyngeal dysphagia leading to failure to thrive, congenital heart disease, hypoglycemia associated with growth hormone deficiency, and mildly dysmorphic facial features are observed. Medical manifestations typically lead to identification of PTLS in infancy; however, those with only behavioral and cognitive manifestations may be identified in later childhood.</Attribute>
                <XRef ID="NBK447920" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">28837307</ID>
                <ID Source="BookShelf">NBK447920</ID>
              </Citation>
              <XRef ID="100038247" DB="Gene" />
              <XRef ID="1713" DB="Orphanet" />
              <XRef ID="C2931246" DB="MedGen" />
              <XRef ID="MONDO:0012574" DB="MONDO" />
              <XRef Type="MIM" ID="610883" DB="OMIM" />
            </Trait>
            <Trait ID="3299" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Familial spontaneous pneumothorax</ElementValue>
                <XRef ID="MONDO:0008259" DB="MONDO" />
                <XRef ID="715219001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pneumothorax, primary spontaneous</ElementValue>
                <XRef ID="Pneumothorax%2C+primary+spontaneous/9123" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PSP</ElementValue>
                <XRef Type="MIM" ID="173600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4997" />
                <XRef ID="4997" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Spontaneous Pneumothorax</Attribute>
              </AttributeSet>
              <XRef ID="2903" DB="Orphanet" />
              <XRef ID="C1868193" DB="MedGen" />
              <XRef ID="MONDO:0008259" DB="MONDO" />
              <XRef Type="MIM" ID="173600" DB="OMIM" />
            </Trait>
            <Trait ID="15944" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nonpapillary renal cell carcinoma</ElementValue>
                <XRef ID="HP:0006770" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0007763" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">RCC</ElementValue>
                <XRef Type="MIM" ID="144700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <XRef ID="422526" DB="Orphanet" />
              <XRef ID="CN074294" DB="MedGen" />
              <XRef ID="MONDO:0007763" DB="MONDO" />
              <XRef Type="MIM" ID="144700" DB="OMIM" />
            </Trait>
            <Trait ID="1028" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Birt-Hogg-Dube syndrome</ElementValue>
                <XRef ID="MONDO:0800444" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BHD syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Birt Hogg Dubé syndrome</ElementValue>
                <XRef ID="1263460007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BHD</ElementValue>
                <XRef Type="MIM" ID="135150" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The clinical characteristics of Birt-Hogg-Dubé syndrome (BHDS) include cutaneous manifestations (fibrofolliculomas, acrochordons, angiofibromas, oral papules, cutaneous collagenomas, and epidermal cysts), pulmonary cysts/history of pneumothorax, and various types of renal tumors. Disease severity can vary significantly even within the same family. Skin lesions typically appear between the second and fourth decades of life and typically increase in size and number with age. Lung cysts are often bilateral and multifocal; most individuals are asymptomatic but at high risk for spontaneous pneumothorax. Individuals with BHDS are at a sevenfold increased risk for renal tumors that can be bilateral and multifocal; median age of renal tumor diagnosis is 48 years. The most common renal tumors are a hybrid of oncocytoma and chromophobe histologic cell types (oncocytic hybrid tumor) and chromophobe histologic cell types. Some families have renal tumor(s) and/or spontaneous pneumothorax without cutaneous manifestations.</Attribute>
                <XRef ID="NBK1522" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2322" />
                <XRef ID="2322" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301695</ID>
                <ID Source="BookShelf">NBK1522</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="KCRNC, 2013">
                <ID Source="PubMed">24319509</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Renal cell carcinoma genetics">
                <ID Source="PubMed">26389510</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Birt-Hogg-Dubé syndrome">
                <URL>https://www.cancer.gov/types/kidney/hp/renal-cell-carcinoma-genetics/bhd-syndrome</URL>
                <CitationText>PDQ® Cancer Genetics Editorial Board. PDQ Birt-Hogg-Dubé Syndrome. Bethesda, MD: National Cancer Institute. Updated &lt;03/08/2021&gt;. Accessed &lt;05/05/2021&gt;.</CitationText>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="122" DB="Orphanet" />
              <XRef ID="C0346010" DB="MedGen" />
              <XRef ID="MONDO:0800444" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS135150" DB="OMIM" />
            </Trait>
            <Trait ID="32349" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Colorectal cancer, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Malignant Colorectal Neoplasm</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Colorectal cancer</ElementValue>
                <XRef ID="UWMG_7884717" DB="CSER _CC_NCGL, University of Washington" />
                <XRef ID="Colorectal+Cancer/1746" DB="Genetic Alliance" />
                <XRef ID="MONDO:0005575" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CRC</ElementValue>
                <XRef ID="GTR000500646" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="114500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Lynch syndrome is characterized by an increased risk for colorectal cancer (CRC) and cancers of the endometrium, ovary, stomach, small bowel, urinary tract, biliary tract, brain (usually glioblastoma), skin (sebaceous adenomas, sebaceous carcinomas, and keratoacanthomas), pancreas, and prostate. Cancer risks and age of onset vary depending on the associated gene. Several other cancer types have been reported to occur in individuals with Lynch syndrome (e.g., breast, sarcomas, adrenocortical carcinoma). However, the data are not sufficient to demonstrate that the risk of developing these cancers is increased in individuals with Lynch syndrome.</Attribute>
                <XRef ID="NBK1211" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301390</ID>
                <ID Source="BookShelf">NBK1211</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Genetics of Colorectal Cancer">
                <ID Source="PubMed">26389505</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="EHTG/ESCP, 2021">
                <ID Source="PubMed">34043773</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/ng151</URL>
                <CitationText>UK NICE Guideline NG151, Colorectal cancer, 2021</CitationText>
              </Citation>
              <XRef ID="C0346629" DB="MedGen" />
              <XRef ID="MONDO:0005575" DB="MONDO" />
              <XRef Type="MIM" ID="114500" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="861" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3299" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Familial spontaneous pneumothorax</ElementValue>
                <XRef ID="MONDO:0008259" DB="MONDO" />
                <XRef ID="715219001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pneumothorax, primary spontaneous</ElementValue>
                <XRef ID="Pneumothorax%2C+primary+spontaneous/9123" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PSP</ElementValue>
                <XRef Type="MIM" ID="173600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4997" />
                <XRef ID="4997" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Spontaneous Pneumothorax</Attribute>
              </AttributeSet>
              <XRef ID="2903" DB="Orphanet" />
              <XRef ID="C1868193" DB="MedGen" />
              <XRef ID="MONDO:0008259" DB="MONDO" />
              <XRef Type="MIM" ID="173600" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="860" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1028" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Birt-Hogg-Dube syndrome</ElementValue>
                <XRef ID="MONDO:0800444" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BHD syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Birt Hogg Dubé syndrome</ElementValue>
                <XRef ID="1263460007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BHD</ElementValue>
                <XRef Type="MIM" ID="135150" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The clinical characteristics of Birt-Hogg-Dubé syndrome (BHDS) include cutaneous manifestations (fibrofolliculomas, acrochordons, angiofibromas, oral papules, cutaneous collagenomas, and epidermal cysts), pulmonary cysts/history of pneumothorax, and various types of renal tumors. Disease severity can vary significantly even within the same family. Skin lesions typically appear between the second and fourth decades of life and typically increase in size and number with age. Lung cysts are often bilateral and multifocal; most individuals are asymptomatic but at high risk for spontaneous pneumothorax. Individuals with BHDS are at a sevenfold increased risk for renal tumors that can be bilateral and multifocal; median age of renal tumor diagnosis is 48 years. The most common renal tumors are a hybrid of oncocytoma and chromophobe histologic cell types (oncocytic hybrid tumor) and chromophobe histologic cell types. Some families have renal tumor(s) and/or spontaneous pneumothorax without cutaneous manifestations.</Attribute>
                <XRef ID="NBK1522" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2322" />
                <XRef ID="2322" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301695</ID>
                <ID Source="BookShelf">NBK1522</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="KCRNC, 2013">
                <ID Source="PubMed">24319509</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Renal cell carcinoma genetics">
                <ID Source="PubMed">26389510</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Birt-Hogg-Dubé syndrome">
                <URL>https://www.cancer.gov/types/kidney/hp/renal-cell-carcinoma-genetics/bhd-syndrome</URL>
                <CitationText>PDQ® Cancer Genetics Editorial Board. PDQ Birt-Hogg-Dubé Syndrome. Bethesda, MD: National Cancer Institute. Updated &lt;03/08/2021&gt;. Accessed &lt;05/05/2021&gt;.</CitationText>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="122" DB="Orphanet" />
              <XRef ID="C0346010" DB="MedGen" />
              <XRef ID="MONDO:0800444" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS135150" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2862957" SubmissionDate="2020-11-26" DateLastUpdated="2020-12-10" DateCreated="2020-12-10">
        <ClinVarSubmissionID localKey="NM_144997.7:c.1285dup|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001450091" DateUpdated="2020-12-10" DateCreated="2020-12-10" Type="SCV" Version="1" SubmitterName="Clinical Genetics and Genomics, Karolinska University Hospital" OrgID="505315" OrganizationCategory="laboratory" OrgAbbreviation="KLINGEN-KUS" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-06-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="39" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_144997.7:c.1285dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8639822</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5003175" SubmissionDate="2022-08-03" DateLastUpdated="2022-08-08" DateCreated="2022-08-08">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_144997_5_FLCN_c_1285dupC" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002557369" DateUpdated="2022-08-08" DateCreated="2022-08-08" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Birt-Hogg-Dube syndrome (MIM#135150) and primary spontaneous pneumothorax (MIM#173600). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0115 - Variants in this gene are known to have variable expressivity (OMIM). (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0302 - Variant is present in gnomAD (v3) &lt;0.001 for a dominant condition (6 heterozygotes, 0 homozygotes). (SP) 0701 - Other NMD-predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. There are at least 10 NMD-predicted likely pathogenic/pathogenic variants in ClinVar. (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. The c.1285dupC variant, along with the c.1285delC variant, are the most common pathogenic variants and have been reported in 20%-24% of families with Birt-Hogg-Dube syndrome (GeneReviews). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_8341</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_144997.5:c.1285dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0007607" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_32</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5042335" SubmissionDate="2022-10-06" DateLastUpdated="2022-10-15" DateCreated="2022-10-15">
        <ClinVarSubmissionID localKey="NM_144997.7:c.1285dup|OMIM:135150" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002579134" DateUpdated="2022-10-15" DateCreated="2022-10-15" Type="SCV" Version="1" SubmitterName="MGZ Medical Genetics Center" OrgID="255845" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="80338682" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_144997.7:c.1285dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="135150" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>ACMG criteria applied: PVS1, PS4, PM2_SUP</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB12035528</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="577420" SubmissionDate="2016-08-10" DateLastUpdated="2022-12-24" DateCreated="2016-08-29">
        <ClinVarSubmissionID localKey="FLCN-42|OMIM:135150" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000298076" DateUpdated="2022-12-24" DateCreated="2016-08-29" Type="SCV" Version="2" SubmitterName="Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia" OrgID="165021" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-07-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">DGD Variant Analysis Guidelines</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/q5qzurm4/dgd_variant_analysis_guidelines.docx</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="17" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="17" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.[His429Profs*27]</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_144997.5:c.1285dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Birt-Hogg-Dube Syndrome</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="135150" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyDescription>Clinical Testing</StudyDescription>
        <Comment>Clinical Testing</Comment>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5446771" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_144997.7:c.1285dup|OMIM:114500;135150;144700;173600;610883" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002804318" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-09-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_144997.7:c.1285dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="114500" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="135150" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="144700" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="173600" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="610883" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7163041" SubmissionDate="2023-03-08" DateLastUpdated="2023-03-11" DateCreated="2023-03-11">
        <ClinVarSubmissionID localKey="variant:8309490" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV003837550" DateUpdated="2023-03-11" DateCreated="2023-03-11" Type="SCV" Version="1" SubmitterName="Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen" OrgID="506385" OrganizationCategory="laboratory" OrgAbbreviation="IMGAG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Disease">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0010615" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh38" Chr="17" alternateAllele="TG" referenceAllele="T" start="17216394" stop="17216394" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">4556530</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="122" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12938820</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="23688" SubmissionDate="2016-10-19" DateLastUpdated="2023-08-13" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607273.0001_PNEUMOTHORAX, PRIMARY SPONTANEOUS" title="FLCN, 1-BP DUP, 1285C_PNEUMOTHORAX, PRIMARY SPONTANEOUS" />
        <ClinVarAccession Accession="SCV000023688" DateUpdated="2023-08-13" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2010-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Based on the numbering system used by Wei et al. (2009), the 1733dupC mutation has been renumbered as 1285dupC. Nickerson et al. (2002) found that 27 (44%) of 62 cases of Birt-Hogg-Dube syndrome (BHD1; 135150) were due to a duplication (1285dupC) or a deletion (1285delC; 607273.0002) of 1 cytosine in a hypermutable C8 tract in exon 11 of the FLCN gene. In 18 (29%) of 62 unrelated BHD patients, they found the 1285dupC mutation, also known as the C9 mutation, resulted in a frameshift and protein truncation. In 9 (15%) of 62 BHD patients, they found the 1285delC mutation, also known as the C7 mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">19562744</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">12204536</ID>
              </Citation>
              <XRef DB="OMIM" ID="135150" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Khoo et al. (2002) found the 1285insC and 1285delC mutations in exon 11 of the FLCN gene in 3 of 4 families with BHD1 as well as in 2 of 4 sporadic cases.</Attribute>
              <Citation>
                <ID Source="PubMed">12471204</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Gunji et al. (2007) identified the 1285insC mutation in a Japanese patient with isolated pulmonary cysts and primary spontaneous pneumothorax (173600), but no renal or skin manifestations of the BHD syndrome. She had her first pneumothorax at age 16 years and had a cousin with spontaneous pneumothorax.</Attribute>
              <Citation>
                <ID Source="PubMed">17496196</ID>
              </Citation>
              <XRef DB="OMIM" ID="173600" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Ren et al. (2008) identified the 1285insC mutation in affected members of a Chinese family with primary spontaneous pneumothorax and pulmonary cysts.</Attribute>
              <Citation>
                <ID Source="PubMed">18505456</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Nahorski et al. (2010), who referred to this mutation as 1285dupC based on numbering of +1 at the A of the initiation codon, found this mutation in 37 individuals from 9 families with BHD syndrome. Five individuals developed a colorectal neoplasm, including 3 with a malignant colorectal neoplasm, suggesting a genotype/phenotype correlation.</Attribute>
              <Citation>
                <ID Source="PubMed">20522427</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <Name>FLCN, 1-BP DUP, 1285C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 1285C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607273.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">PNEUMOTHORAX, PRIMARY SPONTANEOUS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="23687" SubmissionDate="2016-10-19" DateLastUpdated="2023-08-13" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607273.0001_BIRT-HOGG-DUBE SYNDROME 1" title="FLCN, 1-BP DUP, 1285C_BIRT-HOGG-DUBE SYNDROME 1" />
        <ClinVarAccession Accession="SCV000023687" DateUpdated="2023-08-13" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2010-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Based on the numbering system used by Wei et al. (2009), the 1733dupC mutation has been renumbered as 1285dupC. Nickerson et al. (2002) found that 27 (44%) of 62 cases of Birt-Hogg-Dube syndrome (BHD1; 135150) were due to a duplication (1285dupC) or a deletion (1285delC; 607273.0002) of 1 cytosine in a hypermutable C8 tract in exon 11 of the FLCN gene. In 18 (29%) of 62 unrelated BHD patients, they found the 1285dupC mutation, also known as the C9 mutation, resulted in a frameshift and protein truncation. In 9 (15%) of 62 BHD patients, they found the 1285delC mutation, also known as the C7 mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">19562744</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">12204536</ID>
              </Citation>
              <XRef DB="OMIM" ID="135150" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Khoo et al. (2002) found the 1285insC and 1285delC mutations in exon 11 of the FLCN gene in 3 of 4 families with BHD1 as well as in 2 of 4 sporadic cases.</Attribute>
              <Citation>
                <ID Source="PubMed">12471204</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Gunji et al. (2007) identified the 1285insC mutation in a Japanese patient with isolated pulmonary cysts and primary spontaneous pneumothorax (173600), but no renal or skin manifestations of the BHD syndrome. She had her first pneumothorax at age 16 years and had a cousin with spontaneous pneumothorax.</Attribute>
              <Citation>
                <ID Source="PubMed">17496196</ID>
              </Citation>
              <XRef DB="OMIM" ID="173600" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Ren et al. (2008) identified the 1285insC mutation in affected members of a Chinese family with primary spontaneous pneumothorax and pulmonary cysts.</Attribute>
              <Citation>
                <ID Source="PubMed">18505456</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Nahorski et al. (2010), who referred to this mutation as 1285dupC based on numbering of +1 at the A of the initiation codon, found this mutation in 37 individuals from 9 families with BHD syndrome. Five individuals developed a colorectal neoplasm, including 3 with a malignant colorectal neoplasm, suggesting a genotype/phenotype correlation.</Attribute>
              <Citation>
                <ID Source="PubMed">20522427</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <Name>FLCN, 1-BP DUP, 1285C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 1285C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607273.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">BIRT-HOGG-DUBE SYNDROME 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7544027" SubmissionDate="2023-09-01" DateLastUpdated="2023-09-09" DateCreated="2023-09-09">
        <ClinVarSubmissionID localKey="B1" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004032351" DateUpdated="2023-09-09" DateCreated="2023-09-09" Type="SCV" Version="1" SubmitterName="Division of Respiratory Medicine of Juntendo University, Juntendo University Faculty of Medicine and Graduate School of Medicine" OrgID="507239" OrganizationCategory="clinic" OrgAbbreviation="Respi_Juntendo" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>sanger sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002107" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0032445" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0030436" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="absent" Type="Finding">
                <XRef DB="HP" ID="HP:0009726" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_144997.7:c.1285dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="135150" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13811346</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7825899" SubmissionDate="2023-12-21" DateLastUpdated="2023-12-24" DateCreated="2023-12-24">
        <ClinVarSubmissionID localKey="101690787|OMIM:135150" />
        <ClinVarAccession Accession="SCV004188086" DateUpdated="2023-12-24" DateCreated="2023-12-24" Type="SCV" Version="1" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/8ufcwsf2/myriad_genetics_classification_criteria_2023.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="17" alternateAllele="TG" referenceAllele="T" start="17119708" stop="17119708" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">101690787</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="135150" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14104645</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7898318" SubmissionDate="2023-12-21" DateLastUpdated="2024-01-06" DateCreated="2024-01-06">
        <ClinVarSubmissionID localKey="1550771|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004226854" DateUpdated="2024-01-06" DateCreated="2024-01-06" Type="SCV" Version="1" SubmitterName="Mayo Clinic Laboratories, Mayo Clinic" OrgID="500068" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12204536</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18234728</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21538689</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23784378</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26402642</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29548312</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30360018</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31471370</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31958439</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33137092</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33294559</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">35221599</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">35578266</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">35946080</ID>
          </Citation>
          <Comment>PP1, PP4, PS3_supporting, PS4_moderate, PVS1</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="7" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_144997.7:exon 11</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.His429Profs*27</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_144997.7:c.1285dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14104855</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="486687" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2015-10-11">
        <ClinVarSubmissionID localKey="198457|MedGen:C0346010" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000261689" DateUpdated="2024-02-20" DateCreated="2015-10-11" Type="SCV" Version="11" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15852235</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12204536</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12471204</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17496196</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20522427</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.His429Profs*27) in the FLCN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FLCN are known to be pathogenic (PMID: 15852235). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with Birt-Hogg-Dub√© (BHD) syndrome (PMID: 12204536, 12471204, 17496196, 20522427). It has also been observed to segregate with disease in related individuals. This variant is also known as 1733insC, 1740dupC, and 1277insC. ClinVar contains an entry for this variant (Variation ID: 3363). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.17119708_17119709insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0346010" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8833420" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="3582913|FLCN-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004747808" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The FLCN c.1285dupC variant is predicted to result in a frameshift and premature protein termination (p.His429Profs*27). This variant has been reported to be causative for Birt-Hogg-Dubé syndrome (Khoo et al. 2002. PubMed ID: 12471204, listed as 1733insC; Nahorski et al. 2011. PubMed ID: 21538689; Luijten et al. 2013. PubMed ID: 23784378). This variant is reported in 0.044% of alleles in individuals of African descent in gnomAD. However, the quality of data at this genomic position is questionable and allele frequency data should be interpreted with caution. This variant been interpreted as pathogenic in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/3363/). Frameshift variants in FLCN are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_144997.5:c.1285dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">FLCN-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="196779" SubmissionDate="2014-05-06" DateLastUpdated="2015-03-24" DateCreated="2014-01-17">
        <ClinVarSubmissionID localKey="2507_000000" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000114668" DateUpdated="2015-03-24" DateCreated="2014-01-17" Type="SCV" Version="3" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-04-11">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>236</NumberTested>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <TypePlatform>Sanger</TypePlatform>
              <XRef DB="GTR" ID="GTR000501362" URL="http://www.ncbi.nlm.nih.gov/gtr/tests/501362/" />
              <Description>http://genetics.emory.edu/egl/tests/view.php?testid=363</Description>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="44" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="44" />
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <TypePlatform>NGS</TypePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">MM200NG1</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="0" />
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <TypePlatform>NGS</TypePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">MM240NG1</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="0" />
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <TypePlatform>NGS</TypePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">MM243NG1</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="0" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="17" alternateAllele="G" referenceAllele="-" start="17119709" stop="17119710" variantLength="2" />
            <GeneLocation>NM_144997.5:Ex11</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CI023308" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">23757202</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>EGL001</SubmissionName>
          <SubmissionName>EGL002</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1729261" SubmissionDate="2018-11-26" DateLastUpdated="2018-10-10" DateCreated="2018-10-10">
        <ClinVarSubmissionID localKey="DS_46" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000883143" DateUpdated="2018-10-10" DateCreated="2018-10-10" Type="SCV" Version="1" SubmitterName="Equipe Genetique des Anomalies du Developpement, Université de Bourgogne" OrgID="506039" OrganizationCategory="laboratory" OrgAbbreviation="GADteam" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-11-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_144997.5:c.1285dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="135150" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4842992</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2645571" SubmissionDate="2020-04-29" DateLastUpdated="2020-06-18" DateCreated="2020-06-18">
        <ClinVarSubmissionID localKey="NM_144997.5:c.1285dupC|MedGen:CN257768" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001338245" DateUpdated="2020-06-18" DateCreated="2020-06-18" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-02-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15852235</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12204536</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27905298</ID>
          </Citation>
          <Comment>Variant summary: FLCN c.1285dupC (p.His429ProfsX27) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 0.00011 in 245324 control chromosomes (gnomAD). c.1285dupC has been reported in the literature in multiple individuals affected with Birt-Hogg-Dube Syndrome (Schmidt_2005, Hoshika_2016). These data indicate that the variant is very likely to be associated with disease. At least one publication reports this variant has an impact on protein function (Hoshika_2016). Six ClinVar submitters (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_144997.5:c.1285dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Birt-Hogg-DubÃ© Syndrome</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="CN257768" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7346674</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3867572" SubmissionDate="2021-10-09" DateLastUpdated="2021-10-16" DateCreated="2021-10-16">
        <ClinVarSubmissionID localKey="NM_144997.7:c.1285dupC|OMIM:135150" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001976762" DateUpdated="2021-10-16" DateCreated="2021-10-16" Type="SCV" Version="1" SubmitterName="Laboratory of Medical Genetics, National &amp; Kapodistrian University of Athens" OrgID="506664" OrganizationCategory="laboratory" OrgAbbreviation="LMG-NKUA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">34008892</ID>
          </Citation>
          <Comment>PVS1, PM2, PP5</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_144997.7:c.1285dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="135150" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10504991</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4124520" SubmissionDate="2022-04-01" DateLastUpdated="2022-04-02" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="NXST3762|MedGen:C1868193" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002107147" DateUpdated="2022-04-02" DateCreated="2022-03-28" Type="SCV" Version="2" SubmitterName="DASA" OrgID="508087" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12471204</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20522427</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17496196</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12204536</ID>
          </Citation>
          <Comment>The c.1285dupC;p.(His429Profs*27) is a null frameshift variant (NMD) in the FLCN gene and predicts alteration of the nonsense-mediate decay - NMD is present in a relevant exon to the transcript - PVS1. This sequence change has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 3363; PMID: 12471204; PMID: 20522427; PMID: 17496196; PMID: 12204536)PS4_moderate. This variant is not present in population databases (rs80338682- gnomAD; ABraOM no frequency - http://abraom.ib.usp.br.) - PM2. In summary, the currently available evidence indicates that the variant is pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <GeographicOrigin>Brazil</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_144997.7:exon 11</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="80338682" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_144997.7:c.1285dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1868193" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11164938</SubmissionName>
          <SubmissionName>SUB11265037</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4954800" SubmissionDate="2022-04-25" DateLastUpdated="2020-03-25" DateCreated="2020-03-25">
        <ClinVarSubmissionID localKey="NM_144997.5:c.1285dupC|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002530109" DateUpdated="2020-03-25" DateCreated="2020-03-25" Type="SCV" Version="1" SubmitterName="Sema4, Sema4" OrgID="500057" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12471204</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12204536</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15852235</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27905298</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21538689</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Sema4 Curation Guidelines</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/cy0kpury/sema4_variant_curation_guidelines-clinvar_april_2022.docx</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_144997.5:c.1285dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <Comment>The FLCN c.1285dupC (p.H429PfsX27) variant has been reported in heterozygosity in numerous individuals with Birt-Hogg-Dubé syndrome (PMID: 12471204, 12204536, 15852235, 27905298, among others). Functional studies have shown that this variant alters the stability and function of the folliculin protein (PMID: 21538689, 27905298). This variant was identified in two families, where it was found to segregate with the phenotype across six meioses/individuals (PMID: 12471204, 12204536). This variant is a well-established pathogenic variant associated with Birt-Hogg-Dubé syndrome (PMID: 12204536). This variant causes a frameshift at amino acid 429 that results in premature termination 27 amino acids downstream.This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Loss of function variants in FLCN are known to be pathogenic (PMID: 15852235). This variant was observed in 28/245324 chromosomes, with no homozygotes, across all populations according to the Genome Aggregation Database (http://gnomad.broadinstitute.org, PMID: 32461654). This variant has been reported in ClinVar (Variation ID: 3363). Based on the current evidence available, this variant is interpreted as pathogenic.</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB11360768</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="41592" SubmissionDate="2013-01-08" DateLastUpdated="2022-10-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="NM_144997.4:c.1285dupC_NBK1522" title="NM_144997.4:c.1285dupC and Birt-Hogg-Dube Syndrome" />
        <ClinVarAccession Accession="SCV000041592" DateUpdated="2022-10-01" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">12204536</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">12471204</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">15852235</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">17496196</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">18505456</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">20301695</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="BookShelf">NBK1522</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>Assert pathogenicity</Purpose>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="80338682" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_144997.4:c.1285dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0346010" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="642606" SubmissionDate="2022-08-17" DateLastUpdated="2023-03-04" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="GDXSV:236505" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000329354" DateUpdated="2023-03-04" DateCreated="2016-12-06" Type="SCV" Version="9" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Published functional studies demonstrate a damaging effect: inactivates gene expression, disrupts protein stability, inhibits tumor suppression, and down-regulates multiple genes involved in TGF-beta signaling (Hong et al., 2010a; Hong et al., 2010b; Nahorski et al., 2011); Also known as 1733insC; This variant is associated with the following publications: (PMID: 21209915, 23784378, 23416984, 12204536, 27229674, 28152038, 12471204, 21538689, 22146830, 23995526, 24346394, 20573232, 25594584, 19850877, 20618353, 18505456, 27220747, 27734835, 28558743, 28690286, 28151982, 29357828, 30360018, 29548312, 28724667, 26387484, 26028485, 28869776, 22148048, 20522427, 31019283, 32782288, 33726816, 34008892, 30696655)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:22420</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_144997.5:c.1285dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_124_20220817054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_51_20210925044204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_62_20211022152658</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3923776" SubmissionDate="2023-07-12" DateLastUpdated="2023-07-16" DateCreated="2021-11-06">
        <ClinVarSubmissionID localKey="Chr.17_17216394_17216394_T_TG|not provided" />
        <ClinVarAccession Accession="SCV002009954" DateUpdated="2023-07-16" DateCreated="2021-11-06" Type="SCV" Version="3" SubmitterName="Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden" OrgID="505632" OrganizationCategory="clinic" OrgAbbreviation="KGE" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh38" Chr="17" alternateAllele="TG" referenceAllele="T" start="17216394" stop="17216394" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10612882</SubmissionName>
          <SubmissionName>SUB13603663</SubmissionName>
          <SubmissionName>SUB13676335</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7849939" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_144997.7:c.1285dup|OMIM:135150" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004195371" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_144997.7:c.1285dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="135150" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7887645" SubmissionDate="2023-12-22" DateLastUpdated="2024-01-06" DateCreated="2024-01-06">
        <ClinVarSubmissionID localKey="S13295|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004218922" DateUpdated="2024-01-06" DateCreated="2024-01-06" Type="SCV" Version="1" SubmitterName="Quest Diagnostics Nichols Institute San Juan Capistrano" OrgID="500110" OrganizationCategory="laboratory" OrgAbbreviation="Quest Diagnostics" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30360018</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29548312</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29357828</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27734835</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27905298</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27220747</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26028485</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21538689</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20522427</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19562744</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18505456</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17496196</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12471204</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12204536</ID>
          </Citation>
          <Comment>This frameshift variant alters the translational reading frame of the FLCN mRNA and causes the premature termination of FLCN protein synthesis. In the published literature, the variant has been reported in several individuals and families with Birt-Hogg-Dube Syndrome (PMIDs: 12204536 (2002), 12471204 (2002), 17496196 (2007), 18505456 (2008), 26028485 (2015), 27220747 (2016), 27734835 (2017), 27905298 (2016), 29357828 (2018), 29548312 (2018), and 30360018 (2019)). Functional studies found that this variant significantly impaired FLCN protein stability and function (PMIDs: 21538689 (2011) and 27905298 (2016)). Based on the available information, this variant is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Quest Diagnostics criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_144997.6:c.1285dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14108248</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4993028" SubmissionDate="2024-02-06" DateLastUpdated="2024-02-14" DateCreated="2022-07-30">
        <ClinVarSubmissionID localKey="NM_144997.7:c.1285dup|not provided" />
        <ClinVarAccession Accession="SCV002551327" DateUpdated="2024-02-14" DateCreated="2022-07-30" Type="SCV" Version="6" SubmitterName="Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital" OrgID="505691" OrganizationCategory="laboratory" OrgAbbreviation="GM4113, RH" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_144997.7:c.1285dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11858217</SubmissionName>
          <SubmissionName>SUB12396889</SubmissionName>
          <SubmissionName>SUB13715930</SubmissionName>
          <SubmissionName>SUB13716033</SubmissionName>
          <SubmissionName>SUB13754382</SubmissionName>
          <SubmissionName>SUB13762359</SubmissionName>
          <SubmissionName>SUB13765303</SubmissionName>
          <SubmissionName>SUB14210320</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8350842" SubmissionDate="2024-01-24" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="167180|MedGen:CN235283" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004563885" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The FLCN c.1285dupC; p.His429ProfsTer27 variant (rs80338682), also known as 9C, 1733insC, 1740dupC, and 1277insC, is a well-known pathogenic variant that occurs in the mutational sequence hot-spot of eight cytosine nucleotides in exon 11 on the FLCN gene. Both c.1285delC and c.1285dupC have been reported in several patients diagnosed with Birt-Hogg-Dube syndrome (Khoo 2002, Lee 2019, Nahorski 2011, Nickerson 2002, Sattler 2018). The c.1285dupC variant is classified as pathogenic by multiple laboratories in ClinVar (Variation ID: 3363). This variant causes a frameshift by duplicating a single nucleotide, so it is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic References: Khoo SK et al. Clinical and genetic studies of Birt-Hogg-Dube syndrome. J Med Genet. 2002 Dec;39(12):906-12. PMID: 12471204. Lee JH et al. Birt-Hogg-Dube syndrome in Korean: clinicoradiologic features and long term follow-up. Korean J Intern Med. 2019 Jul;34(4):830-840. PMID: 30360018. Nahorski MS et al. Birt Hogg-Dube syndrome-associated FLCN mutations disrupt protein stability. Hum Mutat. 2011 Aug;32(8):921-9. PMID: 21538689. Nickerson ML et al. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome. Cancer Cell. 2002 Aug;2(2):157-64. PMID: 12204536. Sattler EC et al. Delayed diagnosis of Birt-Hogg-Dube syndrome due to marked intrafamilial clinical variability: a case report. BMC Med Genet. 2018 Mar 16;19(1):45. PMID: 29548312.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process 2024</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/xwiqgyug/arup_molecular_germline_variant_investigation_process_arup-info-0022_2024.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.17119716dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN235283" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2023 ARUP ClinVar submission</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="303954" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2014-08-06">
        <ClinVarSubmissionID localKey="a67507|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000185439" DateUpdated="2024-05-01" DateCreated="2014-08-06" Type="SCV" Version="9" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12204536</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12471204</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21538689</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26028485</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27220747</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27734835</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29357828</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29548312</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30360018</ID>
          </Citation>
          <Comment>The c.1285dupC pathogenic mutation, located in coding exon 8 of the FLCN gene, results from a duplication of C at nucleotide position 1285, causing a translational frameshift with a predicted alternate stop codon (p.H429Pfs*27). This recurrent mutation has been reported in multiple families affected with Birt-Hogg-Dub&amp;eacute; syndrome and was shown to result in significant impairment of FLCN protein stability and function (Nickerson ML et al. Cancer Cell. 2002 Aug;2:157-64; Khoo SK et al. J. Med. Genet. 2002 Dec;39:906-12; Nahorski MS et al. Hum. Mutat. 2011 Aug;32:921-9; Nishida C et al. Respir. Med. 2015 Jul;109:923-5; Furuya M et al. Clin. Genet. 2016 Nov;90:403-412; Rossing M et al. J. Hum. Genet. 2017 Feb;62:151-157; Lee JH et al. Korean J. Intern. Med. 2018 Oct). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_144997.5:c.1285dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4719346" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2022-04-11">
        <ClinVarSubmissionID localKey="113918|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002498251" DateUpdated="2024-07-15" DateCreated="2022-04-11" Type="SCV" Version="15" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLCN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="17" alternateAllele="TG" referenceAllele="T" start="17119708" stop="17119708" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="196779" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7544027" TraitType="Finding" MappingType="XRef" MappingValue="HP:0030436" MappingRef="HP">
        <MedGen CUI="C0346011" Name="Fibrofolliculoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="577420" TraitType="Disease" MappingType="Name" MappingValue="Birt-Hogg-Dube Syndrome" MappingRef="Preferred">
        <MedGen CUI="C0346010" Name="Birt-Hogg-Dube syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4124520" TraitType="Disease" MappingType="XRef" MappingValue="C1868193" MappingRef="MedGen">
        <MedGen CUI="C1868193" Name="Familial spontaneous pneumothorax" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="23688" TraitType="Disease" MappingType="Name" MappingValue="PNEUMOTHORAX, PRIMARY SPONTANEOUS" MappingRef="Alternate">
        <MedGen CUI="C1868193" Name="Familial spontaneous pneumothorax" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4993028" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7163041" TraitType="Disease" MappingType="XRef" MappingValue="122" MappingRef="Orphanet">
        <MedGen CUI="CN375946" Name="Birt-Hogg-Dube syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8833420" TraitType="Disease" MappingType="Name" MappingValue="FLCN-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="FLCN-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7887645" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446771" TraitType="Disease" MappingType="XRef" MappingValue="173600" MappingRef="OMIM">
        <MedGen CUI="C1868193" Name="Familial spontaneous pneumothorax" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="23687" TraitType="Disease" MappingType="Name" MappingValue="BIRT-HOGG-DUBE SYNDROME 1" MappingRef="Preferred">
        <MedGen CUI="CN375946" Name="Birt-Hogg-Dube syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7544027" TraitType="Finding" MappingType="XRef" MappingValue="HP:0009726" MappingRef="HP">
        <MedGen CUI="C0022665" Name="Renal neoplasm" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1729261" TraitType="Disease" MappingType="XRef" MappingValue="135150" MappingRef="OMIM">
        <MedGen CUI="CN375946" Name="Birt-Hogg-Dube syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446771" TraitType="Disease" MappingType="XRef" MappingValue="144700" MappingRef="OMIM">
        <MedGen CUI="CN074294" Name="Nonpapillary renal cell carcinoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8350842" TraitType="Disease" MappingType="XRef" MappingValue="CN235283" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5042335" TraitType="Disease" MappingType="XRef" MappingValue="135150" MappingRef="OMIM">
        <MedGen CUI="CN375946" Name="Birt-Hogg-Dube syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7163041" TraitType="Disease" MappingType="XRef" MappingValue="HP:0010615" MappingRef="HP">
        <MedGen CUI="C0206731" Name="Angiofibromas" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4954800" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="486687" TraitType="Disease" MappingType="XRef" MappingValue="C0346010" MappingRef="MedGen">
        <MedGen CUI="C0346010" Name="Birt-Hogg-Dube syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="303954" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446771" TraitType="Disease" MappingType="XRef" MappingValue="610883" MappingRef="OMIM">
        <MedGen CUI="C2931246" Name="Potocki-Lupski syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7544027" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002107" MappingRef="HP">
        <MedGen CUI="C0032326" Name="Pneumothorax" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7849939" TraitType="Disease" MappingType="XRef" MappingValue="135150" MappingRef="OMIM">
        <MedGen CUI="CN375946" Name="Birt-Hogg-Dube syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7898318" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="41592" TraitType="Disease" MappingType="XRef" MappingValue="C0346010" MappingRef="MedGen">
        <MedGen CUI="C0346010" Name="Birt-Hogg-Dube syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7544027" TraitType="Disease" MappingType="XRef" MappingValue="135150" MappingRef="OMIM">
        <MedGen CUI="CN375946" Name="Birt-Hogg-Dube syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446771" TraitType="Disease" MappingType="XRef" MappingValue="135150" MappingRef="OMIM">
        <MedGen CUI="CN375946" Name="Birt-Hogg-Dube syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7825899" TraitType="Disease" MappingType="XRef" MappingValue="135150" MappingRef="OMIM">
        <MedGen CUI="CN375946" Name="Birt-Hogg-Dube syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3923776" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4719346" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2862957" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7544027" TraitType="Finding" MappingType="XRef" MappingValue="HP:0032445" MappingRef="HP">
        <MedGen CUI="C0546483" Name="Pulmonary cyst" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3867572" TraitType="Disease" MappingType="XRef" MappingValue="135150" MappingRef="OMIM">
        <MedGen CUI="CN375946" Name="Birt-Hogg-Dube syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="642606" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446771" TraitType="Disease" MappingType="XRef" MappingValue="114500" MappingRef="OMIM">
        <MedGen CUI="C0346629" Name="Colorectal cancer" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="2" DateDeleted="2022-01-11">SCV000603726</Accession>
        <Description>not specified</Description>
      </SCV>
      <SCV>
        <Accession Version="1" DateDeleted="2021-06-21">SCV000919364</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

